Skip to main content

Table 1 Prevalence and determinants of virological failure on ART among PLWH

From: Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study

Variables

VL ≥ 1000 copies/ml

Total N

ORu

ORm

Virologic failure

n = 2156 (rate, n/N%)

Socio-demographics

Gender

  Female

710 (36.90)

1925

1.0(ref)

1.0(ref)

  Male

1446 (44.70)

3232

1.39 (1.23–1.56)***

1.25 (1.03–1.50)***

Age

  ≤ 15

172 (48.86)

352

1.0 (Ref.)

 

  15 ~ 40

1423 (41.45)

3433

0.74 (0.59–0.92) ***

 

  >40

533 (40.94)

1302

0.72 (0.57–0.92) ***

–

  Unknown

28 (40.00)

70

–

 

Occupation

  Employed

37 (34.91)

106

1.0 (Ref.)

 

  Peasant

1736 (41.85)

4148

1.34 (0.90–2.01)

 

  Students and children

136 (46.74)

291

1.64 (1.03–2.60)**

–

  Unknown

247 (40.36)

612

–

 

Current marital status

  Married

1406 (41.80)

3366

1.0 (Ref.)

 

  Single

428 (45.77)

934

1.18 (1.02–1.36) **

 

  Widowed or Divorced

99 (35.87)

276

0.78 (0.60–1.01)*

–

  Unknown

223 (38.38)

581

–

 

Ethnicity

(0.00)

   

  Yi

2137 (41.70)

5125

1.0 (Ref.)

 

  Han and others

19 (59.38)

32

2.04 (1.01–4.15)**

–

Education level

  Illiteracy

1339 (42.58)

3145

1.0 (Ref.)

1.0 (Ref.)

  Primary school

581 (40.77)

1425

0.93 (0.82–1.05)*

0.77 (0.66–0.89)**

  Secondary or above

70 (38.67)

181

0.85 (0.63–1.16)

0.69 (0.46–1.04)

  Unknown

166 (40.89)

406

–

 

HIV transmission route

  Heterosexual behaviors

715 (37.10)

1927

1.0 (Ref.)

1.0 (Ref.)

  Drug injection

747 (43.08)

1734

1.28 (1.12–1.47)***

1.12 (0.93–1.35)

  Heterosexual behaviors and drug injection

325 (49.02)

663

1.63 (1.36–1.95) ***

1.44 (1.15–1.82)**

  Mother to child

163 (48.95)

333

1.63 (1.29–2.05) ***

1.58 (1.21–2.08)**

  Others and unknown

206 (41.20)

500

–

–

The first CD4+counts, counts/ul

  ≤ 200

346 (46.82)

739

1.0 (Ref.)

 

  200 ~ 500

986 (41.29)

2388

0.80 (0.68–0.94)**

 

  >500

646 (40.68)

1588

0.78 (0.65–0.93)**

–

  Unknown

178 (40.27)

442

–

 

Stage of disease

  HIV

784 (37.44)

2094

1.0 (Ref.)

1.0 (Ref.)

  AIDS

985 (44.49)

2214

1.34 (1.19–1.51) ***

1.35 (1.17–1.55)***

  Unknown

387 (45.58)

849

–

 

HIV-related behaviors

Needle sharing

  Had never used illicit drugs and shared the needle

1001 (39.03)

2565

1.0 (Ref.)

1.0 (Ref.)

  Had shared needle for 1 ~ 4 times

519 (43.43)

1195

1.20 (1.04–1.38)**

1.34 (1.09–1.65)**

  Had shared needle ≥5 times

421 (48.00)

877

1.44 (1.24–1.68) ***

1.52 (1.21–1.91)***

  Unknown

215 (41.35)

520

–

 

Number of casual sexual partners

  0

1089 (42.51)

2562

1.0 (Ref.)

 

  1 ~ 4

508 (38.99)

1303

0.86 (0.75–0.99)**

 

  ≥ 5

344 (44.56)

772

1.09 (0.92–1.28)

–

  Unknown

215 (41.35)

520

–

 

History of sexually transmitted diseases except for HIV

  Never

1494 (42.53)

3513

1.0 (Ref.)

 

  Ever

100 (38.46)

260

0.85 (0.65–1.09)

–

ART related information

Time of ART

  < 12

304 (43.55)

698

1.0 (Ref.)

1.0 (Ref.)

  12 ~ 36

682 (40.38)

1689

0.88 (0.73–1.05)*

0.72 (0.60–0.92)**

  > 36

728 (40.00)

1820

0.86 (0.72–1.03)*

0.66 (0.53–0.83)***

  Unknown

442 (46.53)

950

–

 

Initial regimen of ART

  TDF + 3TC + EFV/NVP

1202 (39.97)

3007

1.0 (Ref.)

 

  AZT + 3TC + EFV/NVP

444 (44.36)

1001

1.20 (1.04–1.38)**

 

  LPV/r + 3TC + AZT/TDF

48 (33.33)

144

0.75 (0.53–1.07)*

 

  Unknown

462 (45.97)

1005

–

=

Replacement of ART regimen

  Never

1535 (40.16)

3822

1.0 (Ref.)

1.0 (Ref.)

  Ever

181 (46.65)

388

1.30 (1.06–1.61)**

1.48 (1.12–1.96)**

  1. ORu univariate odds ratios, ORm multivariate odds ratios, CI confidence interval, TDF tenofovir, 3TC lamivudine, NVP nevirapine, EFV efavirenz, AZT Zidovudine, LPV/r fosamprenavir/ritonavir
  2. Variables with p < 0.2 in the univariate analysis as candidates were selected by a summary multiple logistic regression model
  3. *P value< 0.2; **P value< 0.05; ***P value< 0.001